Tempo Automation (TMPOQ) S-4/A6 May 21Registration of securities issued in business combination transactions (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information	9 Months Ended
Document and Entity Information	Dec. 31, 2020
Document and Entity Information [Abstract]
Document Type	S-4/A
Entity Registrant Name	ACE Convergence Acquisition Corp.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001813658
Amendment Flag	true
Amendment Description	Amendment No. 3

BALANCE SHEET

BALANCE SHEET	Dec. 31, 2020USD ($)
Current assets
Cash	$ 792,416
Prepaid expenses	343,839
Total Current Assets	1,136,255
Cash and marketable securities held in Trust Account	230,091,362
TOTAL ASSETS	231,227,617
Current liabilities
Current liabilities - accounts payable and accrued expenses	859,811
Warrant Liability	25,489,000
Deferred underwriting fee payable	8,050,000
Total Liabilities	34,398,811
Commitments
Class A ordinary shares subject to possible redemption, 19,182,880 shares at $10.00 per share redemption value	191,828,800
Shareholders' Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital	14,187,406
Accumulated deficit	(9,188,357)
Total Shareholders' Equity	5,000,006
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	231,227,617
Class A ordinary shares
Shareholders' Equity
Ordinary shares	382
Total Shareholders' Equity	382
Class B ordinary shares
Shareholders' Equity
Ordinary shares	$ 575

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical)	Dec. 31, 2020$ / sharesshares
Preference shares, par value \| $ / shares	$ 0.0001
Preference shares, shares authorized	5,000,000
Preference shares, shares issued	0
Preference shares, shares outstanding	0
Class A ordinary shares
Ordinary shares, par value \| $ / shares	$ 0.0001
Ordinary shares, shares authorized	500,000,000
Ordinary shares, shares issued	3,817,120
Ordinary shares, shares outstanding	1,268,220
Ordinary shares, shares subject to possible redemption	19,182,880
Ordinary shares, redemption value per share \| $ / shares	$ 10
Class B ordinary shares
Ordinary shares, par value \| $ / shares	$ 0.0001
Ordinary shares, shares authorized	50,000,000
Ordinary shares, shares issued	5,750,000
Ordinary shares, shares outstanding	5,750,000

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS	9 Months Ended
STATEMENT OF OPERATIONS	Dec. 31, 2020USD ($)$ / sharesshares
Formation and operating costs	$ 1,125,460
Loss from operations	(1,125,460)
Other income/(expense):
Interest earned on marketable securities held in Trust Account	91,362
Offering costs allocated to warrant liability	(667,259)
Changes in fair value of warrant liability	(7,487,000)
Total other income (expense)	(8,062,897)
Net Loss	$ (9,188,357)
Class A ordinary shares
Other income/(expense):
Weighted average shares outstanding of redeemable ordinary shares \| shares	23,000,000
Basic and diluted net income per share \| $ / shares	$ 0
Class B ordinary shares
Other income/(expense):
Weighted average shares outstanding of redeemable ordinary shares \| shares	5,529,817
Basic and diluted net income per share \| $ / shares	$ (1.68)

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - 9 months ended Dec. 31, 2020	Class A ordinary sharesAFN (؋)shares	Class A ordinary sharesUSD ($)shares	Class B ordinary sharesOrdinary SharesUSD ($)shares	Additional Paid in CapitalUSD ($)	Accumulated DeficitUSD ($)	USD ($)
Balance at the beginning at Mar. 30, 2020	؋ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Mar. 30, 2020			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	؋ 0	0	$ 575	24,425	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)			5,750,000
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability \| $		$ 2,300		205,989,863		205,989,863
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability (in shares)	23,000,000	23,000,000
Class A ordinary shares subject to possible redemption \| $		$ (1,918)		(191,826,882)		(191,828,800)
Class A ordinary shares subject to possible redemption (in shares)	(19,182,880)	(19,182,880)
Net loss \| $					(9,188,357)	(9,188,357)
Balance at the end at Dec. 31, 2020 \| $		$ 382	$ 575	$ 14,187,406	$ (9,188,357)	$ 5,000,006
Balance at the end (in shares) at Dec. 31, 2020	3,817,120	3,817,120	5,750,000

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)	9 Months Ended
	Dec. 31, 2020shares
Private placement warrants issued	6,600,000
Class A ordinary shares
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability (in shares)	23,000,000

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS	9 Months Ended
STATEMENTS OF CASH FLOWS	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (9,188,357)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(91,362)
Change in fair value of warrant liability	7,487,000
Offering costs related to allocation to warrant liability	667,259
Payment of formation costs through promissory note - related party	1,548
Changes in operating assets and liabilities:
Prepaid expenses	(343,839)
Accounts payable and accrued expenses	859,811
Net cash used in operating activities	(607,940)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B ordinary shares to the Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	225,400,000
Proceeds from sale of Private Placement Warrants	6,600,000
Proceeds of promissory note - related party	62,558
Repayment of promissory note - related party	(186,760)
Payments of offering costs	(500,442)
Net cash provided by financing activities	231,400,356
Net Change in Cash	792,416
Cash - Ending	792,416
Non-Cash Investing and Financing Activities:
Initial classification of ordinary shares subject to possible redemption	200,344,480
Change in value of Class A ordinary shares subject to possible redemption	(9,544,360)
Initial classification of warrant liability	18,002,000
Deferred underwriting fee payable	8,050,000
Payment of offering costs through promissory note - related party	$ 122,654

ORGANIZATION AND PLAN OF BUSINE

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS	9 Months Ended
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS	Dec. 31, 2020
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS	NOTE 1—ORGANIZATION AND PLAN OF BUSINESS OPERATIONS ACE Convergence Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on March 31, 2020. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses (a “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus on businesses in the IT infrastructure software and semiconductor sector. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has one subsidiary, ACE Convergence Subsidiary Corp., a wholly-owned subsidiary of the Company incorporated in Delaware on January 6, 2021 ("Merger Sub"). As of December 31, 2020, the Company had not commenced any operations. All activities from inception to December 31, 2020 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on July 27, 2020. On July 30, 2020, the Company consummated the Initial Public Offering of 23,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units offered, the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,600,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Company’s sponsor, ACE Convergence Acquisition LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $6,600,000, which is described in Note 5. Transaction costs charged to equity amounted to $13,273,096 consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $623,096 of other offering costs. Of this amount, $12,605,837 was offset against the proceeds of the Initial Public Offering in equity and $667,259 was expensed as transaction costs. Following the closing of the Initial Public Offering on July 30, 2020, an amount of $230,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) which was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a‑7 of the Investment Company Act, as determined by the Company, until the earliest of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Nasdaq listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially to be $10.00 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding public shares, subject to certain limitations as described in the prospectus. The per-share amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote in person or by proxy at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares. The Company will have until January 30, 2022 (the “Combination Period”) as may be extended from time to time by the Company as a result of a shareholder vote to amend its Amended and Restated Memorandum and Articles of Association (an “Extension Period”) to consummate a Business Combination. However, if the Company has not completed a Business Combination within the Combination Period or any Extension Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period or any Extension Period. The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period or any Extension Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period or any Extension Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period or any Extension Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern As of December 31, 2020, the Company had $792,416 in its operating bank accounts, $230,091,362 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its ordinary shares in connection there with and working capital of $276,444. The Company intends to complete a Business Combination by January 30, 2022. However, in the absence of a completed Business Combination, the Company may require additional capital. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company's assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern,” the Company has until January 30, 2022 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 30, 2022.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 5) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of ordinary shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, in consultation with the Company’s audit committee, management concluded that the Company’s Public and Private Placement Warrants are not indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, in consultation with the Company’s audit committee, management concluded the tender offer provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. Notwithstanding the above mentioned impact, the Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. The following table reflects the Company’s balance sheet, statement of operations, and statement of cash flows as of and for the periods indicated below. As Previously As Reported Adjustments Restated Balance sheet as of July 30, 2020 (audited) Warrant Liability $ — $ 18,002,000 $ 18,002,000 Total Liabilities 8,627,236 18,002,000 26,629,236 Ordinary Shares Subject to Possible Redemption 218,346,480 (18,002,000) 200,344,480 Class A Ordinary Shares 117 180 297 Additional Paid-in Capital 5,004,732 667,079 5,671,811 Accumulated Deficit (5,415) (667,259) (672,674) Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 15,502,000 $ 15,502,000 Total Liabilities 8,095,030 15,502,000 23,597,030 Ordinary Shares Subject to Possible Redemption 218,272,100 (15,502,000) 202,770,110 Class A Ordinary Shares 117 155 272 Additional Paid-in Capital 5,079,112 (1,832,896) 3,246,216 Accumulated Deficit (79,802) 1,832,741 1,752,939 Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 25,489,000 $ 25,489,000 Total Liabilities 8,909,811 25,489,000 34,398,811 Ordinary Shares Subject to Possible Redemption 217,317,800 (25,489,000) 191,828,800 Class A Ordinary Shares 127 255 382 Additional Paid-in Capital 6,033,402 8,154,004 14,187,406 Accumulated Deficit (1,034,098) (8,154,259) (9,188,357) Three months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 2,500,000 $ 2,500,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (75,068) 1,832,741 1,757,673 Basic and diluted net loss per share, Class B (0.02) 0.32 0.30 For the Period from March 31, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 2,500,000 $ 2,500,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (79,802) 1,832,741 1,752,939 Basic and diluted net loss per share, Class B (0.02) 0.32 0.30 For the Period from March 31, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 7,487,000 $ 7,487,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (1,034,098) (8,154,259) (9,188,357) Basic and diluted net loss per share, Class B (0.19) (1.49) (1.68) As Previously As Reported Adjustments Restated Cash Flow Statement for the Period from March 31, 2020 (inception) to September 30, 2020 (unaudited) Net income (loss) $ (79,802) $ 1,832,741 1,752,939 Change in fair value of warrant liability — (2,500,000) (2,500,000) Offering costs allocated to warrant liability 667,259 667,259 Initial classification of warrant liability — 18,002,000 18,002,000 Initial classification of common stock subject to possible redemption 218,346,480 (18,002,000) 200,344,480 Change in value of common stock subject to possible redemption (74,380) 2,425,620 2,351,240 Cash Flow Statement for the Period from March 31, 2020 (inception) to December 31, 2020 (audited) Net loss $ (1,034,098) $ (8,154,259) $ (9,188,357) Change in fair value of warrant liability 7,487,000 7,487,000 Offering costs allocated to warrant liability 667,259 667,259 Initial classification of warrant liability 18,002,000 18,002,000 Initial classification of common stock subject to possible redemption 218,346,480 (18,002,000) 200,344,480 Change in value of common stock subject to possible redemption (1,028,680) (8,515,680) (9,544,360)

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, 21,731,790 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. In accordance with ASC 825-10 “Financial Instruments”, the Company has concluded that a portion of the transaction costs which directly related to the Initial Public Offering and the Private Placement, which were previously charged to stockholder’s equity, should be allocated to the Warrants used on their relative fair value against total proceeds, and recognized as transaction costs in the statement of operations. Accordingly, offering costs amounting to $12,605,837 were charged to shareholders’ equity upon the completion of the Initial Public Offering and the remaining $667,259 of offering costs related to the warrant liability was charged to operations. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. . The fair value of the warrants issued in the IPO has been estimated using a Monte Carlo simulation methodology as of the date of the IPO and such warrants’ quoted market price as of December 31, 2020. The private placement warrants were valued using a Modified Black Scholes Option Pricing Model. Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 18,100,000 Class A ordinary shares in the calculation of diluted income per ordinary share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares, by the weighted average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from March 31, 2020 (inception) Through December 31, 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 91,362 Net Earnings $ 91,362 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted (1) 23,000,000 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (9,188,357) Redeemable Net Earnings $ (91,362) Non-Redeemable Net Loss $ (9,279,719) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted (1) 5,529,817 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (1.68) (1) As of December 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s shareholders. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying financial statements, primarily due to their short-term nature. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
INITIAL PUBLIC OFFERING	Dec. 31, 2020
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 4—INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 8).

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
PRIVATE PLACEMENT	Dec. 31, 2020
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 5—PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,600,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $6,600,000. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 8). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period or any Extension Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6—RELATED PARTY TRANSACTIONS Founder Shares In May 2020, the Sponsor purchased 5,750,000 of the Company’s Class B ordinary shares (the “Founder Shares”) for an aggregate consideration of $25,000. On May 29, 2020, the Sponsor transferred an aggregate of 155,000 Founder Shares to certain members of the Company’s management team. The Founder Shares included an aggregate of up to 750,000 shares that were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised, so that the number of Founder Shares would equal 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option on July 30, 2020, no Founder Shares are subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Promissory Note — Related Party On May 28, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2020 and (ii) the completion of the Initial Public Offering. The borrowings outstanding under the Promissory Note of $186,760 were repaid as of December 31, 2020. Working Capital Facility On August 12, 2020, the Company entered into a working capital facility (the "Working Capital Facility") with ASIA-IO Advisors Limited ("ASIA-IO"), an affiliate of the Company, in the aggregate amount of $1,500,000. The funds from the Working Capital Facility shall be utilized to finance transaction costs in connection with a Business Combination. The Working Capital Facility is non-interest bearing, non-convertible and due to be repaid upon the consummation of a Business Combination. In return, the Company deposited $900,000 into an account held by ASIA-IO, from which the Company may make fund withdrawals for up to $1,500,000. Withdrawals from the working capital facility will first reduce the deposit amount on account. Any outstanding amounts deposited with ASIA-IO upon the completion of a Business Combination or dissolution of the Company, shall be returned to the Company. In November 2020, the deposit amount was reduced by $849,960. As of December 31, 2020, the company had no outstanding borrowings under the working capital facility. Administrative Services Agreement The Company entered into an agreement, commencing on July 28, 2020, to pay the Sponsor up to $10,000 per month for office space, administrative and support services. On November 27, 2020, the Company amended the administrative services agreement, whereas the support services was reassigned to ASIA-IO, retroactively effective from November 1, 2020. In addition, the Sponsor waived $30,000 in fees due to them. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees. For the period from March 31, 2020 (inception) through December 31, 2020, the Company incurred and paid $20,000, in fees for these services. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2020, the Company had no outstanding borrowings under the Working Capital Loans.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2020
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 7—COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management is continuing to evaluate the impact of the COVID‑19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights Pursuant to a registration rights agreement entered into on July 27, 2020, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement In connection with the Initial Public Offering, the underwriters were paid a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	9 Months Ended
SHAREHOLDERS' EQUITY	Dec. 31, 2020
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY	NOTE 8—SHAREHOLDERS’ EQUITY Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2020, there were no preference shares issued or outstanding. Class A Ordinary Shares — The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At December 31, 2020, there were 3,817,120 Class A ordinary shares issued and outstanding, excluding 19,182,880 Class A ordinary shares subject to possible redemption. Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At December 31, 2020, there were 5,750,000 Class B ordinary shares issued and outstanding. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters submitted to a vote of shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 20% of the sum of all ordinary shares issued and outstanding upon completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Business Combination.

WARRANT LIABILITY

WARRANT LIABILITY	9 Months Ended
WARRANT LIABILITY	Dec. 31, 2020
WARRANT LIABILITY
WARRANT LIABILITY	NOTE 9 — WARRANT LIABILITY Warrants — Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available, including in connection with a cashless exercise. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Public Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a Public Warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to qualify the shares under applicable blue sky laws to the extent an exemption is not available. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: · in whole and not in part; · at a price of $0.01 per Public Warrant; · upon not less than 30 days’ prior written notice of redemption to each warrant holder; and · if, and only if, the reported last sale price of the Class A ordinary shares for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period or any Extension Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
FAIR VALUE MEASUREMENTS	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10 — FAIR VALUE MEASUREMENTS The fair value of the Company's financial assets and liabilities reflects management's estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Level 2: Level 3: The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts. At December 31, 2020, assets held in the Trust Account were comprised of $82 in cash and $230,091,280 in U.S. Treasury securities. During the period from March 31, 2020 (inception) to December 31, 2020, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s held-to-maturity assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. The gross holding gains and fair value of held-to-maturity securities at December 31, 2020, are as follows: Gross Amortized Holding Held-To-Maturity Level Cost Gain Fair Value December 31, 2020 U.S. Treasurey Securities (Mature on 01/28/2021) 1 $ 230,091,280 $ 7,515 $ 230,098,795 Liabilities: Warrant Liability – Public Warrants 1 $ 15,985,000 Warrant Liability – Private Placement Warrants 3 $ 9,504,000 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Company’s consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations. Initial Measurement The Company established the initial fair value for the Warrants on July 30, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model for the Public Warrants and a Black-Scholes model for the Private Placement Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A ordinary shares and one-fourth of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption, Class A ordinary shares and Class B ordinary shares based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Public Warrants and the Black-Scholes model for the Private Placement Warrants were as follows at initial measurement: Input July 30, 2020 Risk-free interest rate 0.32 % Expected term (years) 5.92 Expected volatility 21.5 % Exercise price $ 11.50 Fair value of Units $ 10.00 On July 30, 2020, the fair value of the Public Warrants was determined to be $0.98 per warrant for an aggregate value of $11.3 million. The fair value of the Private Placement Warrants was determined to be $1.02 per warrant for an aggregate value of $6.7 million. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market. The key inputs into the Black-Scholes model for the Private Placement Warrants were as follows as of December 31, 2020: December 31,2020 (Initial Input Measurement) Risk-free interest rate 0.36 % Expected term (years) 5.49 Expected volatility 22.7 % Exercise price $ 11.50 Fair value of Shares $ 10.22 As of December 31, 2020, the derived fair value of the Private Placement Warrants was determined to be $1.44 per warrant for an aggregate value of $9.1 million. The observable fair value of the Public Warrants was $1.39 per warrant for an aggregate value of $16.0 million. The following table presents the changes in the fair value of warrant liabilities: Private Warrant Placement Level Public Level Liabilities Fair value as of May 28 2020 $ — $ — $ — Initial measurement on July 30, 2020 6,732,000 3 11,270,000 3 18,002,000 Change in fair value 2,772,000 4,715,000 7,487,000 Fair value as of December 31, 2020 $ 9,504,000 3 $ 15,985,000 1 $ 25,489,000 Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $11,270,000 during the period from July 30, 2020 through December 31, 2020. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review , other than described as in footnote 2 and below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. Merger Agreement On January 7, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Merger Sub, and Achronix Semiconductor Corporation, a Delaware corporation (“Achronix”). Pursuant to the transactions contemplated by the terms of the Merger Agreement, and subject to the satisfaction or waiver of certain conditions set forth therein, Merger Sub will merge with and into Achronix, with Achronix surviving the merger and as a wholly owned subsidiary of the Company (the “Merger”) (the transactions contemplated by the Merger Agreement, the “Business Combination”). Prior to the closing of the Business Combination, the Company shall domesticate as a Delaware Corporation. Upon the effective time of the Merger, the Company shall immediately be renamed “Achronix Semiconductor Corporation.” Pursuant to the Merger Agreement, and subject to the approval of the Company’s shareholders, among other things, upon consummation of the Merger: (i) all of the equity interests of Achronix will be converted into the right to receive shares of common stock, par value $0.001 per share, of the Company (“ACE Common Stock”) and an aggregate of $50 million in cash; and (ii) all options to purchase and restricted stock units for shares of Achronix Common Stock outstanding as of immediately prior to the Merger will be converted into options to purchase and restricted stock units for share of New Achronix Common stock. In connection with the execution of the Merger Agreement, (a) the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (collectively, the “PIPE Investors”) pursuant to, and on the terms and subject to the conditions of which, the PIPE Investors have collectively subscribed for 15,000,000 shares of ACE Common Stock for an aggregate purchase price equal to $150,000,000 (the “PIPE Investment”), a portion of which is expected to be funded by one or more affiliates of the Sponsor. The PIPE Investment will be consummated substantially concurrently with the Closing, subject to the terms and conditions contemplated by the Subscription Agreements; (b) certain affiliates of the Sponsor (the “Backstop Investor”) entered into a backstop subscription agreement (the “Backstop Subscription Agreement”) with the Company, pursuant to, and on the terms and subject to the conditions on which, the Backstop Investor has committed to purchase, following the Domestication and prior to the Closing, shares of the Company’s common stock, par value $0.001 per share, as such shares will exist as common stock following the Domestication, in a private placement for a purchase price of $10.00 per share to backstop certain redemptions by the Company’s shareholders; and (c) the Company also announced entry into a Support Agreement (the “Sponsor Support Agreement”), by and among the Company, the Sponsor, Achronix and certain other parties thereto, pursuant to which the Sponsor and each director and officer of the Company agreed to, among other things, vote in favor of the Merger Agreement and the transactions contemplated thereby, in each case, subject to the terms and conditions contemplated by the Sponsor Support Agreement. In addition, the Company has entered into a Support Agreement (the “Company Support Agreement”) by and among the Company, Achronix and certain stockholders of Achronix (the “Key Stockholders”), pursuant to which the Key Stockholders have agreed to, among other things, vote in favor of the Merger Agreement and the transactions contemplated thereby, in each case, subject to the terms and conditions contemplated by the Company Support Agreement. The Merger Agreement contains customary representations, warranties and covenants by the parties thereto and the Closing is subject to certain conditions as further described in the Merger Agreement.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020, 21,731,790 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Offering Costs	Offering Costs Offering costs consist of underwriting, legal, accounting and other expenses incurred through the Initial Public Offering that are directly related to the Initial Public Offering. In accordance with ASC 825-10 “Financial Instruments”, the Company has concluded that a portion of the transaction costs which directly related to the Initial Public Offering and the Private Placement, which were previously charged to stockholder’s equity, should be allocated to the Warrants used on their relative fair value against total proceeds, and recognized as transaction costs in the statement of operations. Accordingly, offering costs amounting to $12,605,837 were charged to shareholders’ equity upon the completion of the Initial Public Offering and the remaining $667,259 of offering costs related to the warrant liability was charged to operations.
Warrant Liability	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. . The fair value of the warrants issued in the IPO has been estimated using a Monte Carlo simulation methodology as of the date of the IPO and such warrants’ quoted market price as of December 31, 2020. The private placement warrants were valued using a Modified Black Scholes Option Pricing Model.
Income Taxes	Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 18,100,000 Class A ordinary shares in the calculation of diluted income per ordinary share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income per share, basic and diluted, for Class A redeemable ordinary shares is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable ordinary shares is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares, by the weighted average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from March 31, 2020 (inception) Through December 31, 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 91,362 Net Earnings $ 91,362 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted (1) 23,000,000 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (9,188,357) Redeemable Net Earnings $ (91,362) Non-Redeemable Net Loss $ (9,279,719) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted (1) 5,529,817 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (1.68) (1) As of December 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s shareholders.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying financial statements, primarily due to their short-term nature.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of the restatement on financial statements	The following table reflects the Company’s balance sheet, statement of operations, and statement of cash flows as of and for the periods indicated below. As Previously As Reported Adjustments Restated Balance sheet as of July 30, 2020 (audited) Warrant Liability $ — $ 18,002,000 $ 18,002,000 Total Liabilities 8,627,236 18,002,000 26,629,236 Ordinary Shares Subject to Possible Redemption 218,346,480 (18,002,000) 200,344,480 Class A Ordinary Shares 117 180 297 Additional Paid-in Capital 5,004,732 667,079 5,671,811 Accumulated Deficit (5,415) (667,259) (672,674) Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 15,502,000 $ 15,502,000 Total Liabilities 8,095,030 15,502,000 23,597,030 Ordinary Shares Subject to Possible Redemption 218,272,100 (15,502,000) 202,770,110 Class A Ordinary Shares 117 155 272 Additional Paid-in Capital 5,079,112 (1,832,896) 3,246,216 Accumulated Deficit (79,802) 1,832,741 1,752,939 Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 25,489,000 $ 25,489,000 Total Liabilities 8,909,811 25,489,000 34,398,811 Ordinary Shares Subject to Possible Redemption 217,317,800 (25,489,000) 191,828,800 Class A Ordinary Shares 127 255 382 Additional Paid-in Capital 6,033,402 8,154,004 14,187,406 Accumulated Deficit (1,034,098) (8,154,259) (9,188,357) Three months ended September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 2,500,000 $ 2,500,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (75,068) 1,832,741 1,757,673 Basic and diluted net loss per share, Class B (0.02) 0.32 0.30 For the Period from March 31, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 2,500,000 $ 2,500,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (79,802) 1,832,741 1,752,939 Basic and diluted net loss per share, Class B (0.02) 0.32 0.30 For the Period from March 31, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ 7,487,000 $ 7,487,000 Offering costs allocated to warrant liability — 667,259 667,259 Net loss (1,034,098) (8,154,259) (9,188,357) Basic and diluted net loss per share, Class B (0.19) (1.49) (1.68) As Previously As Reported Adjustments Restated Cash Flow Statement for the Period from March 31, 2020 (inception) to September 30, 2020 (unaudited) Net income (loss) $ (79,802) $ 1,832,741 1,752,939 Change in fair value of warrant liability — (2,500,000) (2,500,000) Offering costs allocated to warrant liability 667,259 667,259 Initial classification of warrant liability — 18,002,000 18,002,000 Initial classification of common stock subject to possible redemption 218,346,480 (18,002,000) 200,344,480 Change in value of common stock subject to possible redemption (74,380) 2,425,620 2,351,240 Cash Flow Statement for the Period from March 31, 2020 (inception) to December 31, 2020 (audited) Net loss $ (1,034,098) $ (8,154,259) $ (9,188,357) Change in fair value of warrant liability 7,487,000 7,487,000 Offering costs allocated to warrant liability 667,259 667,259 Initial classification of warrant liability 18,002,000 18,002,000 Initial classification of common stock subject to possible redemption 218,346,480 (18,002,000) 200,344,480 Change in value of common stock subject to possible redemption (1,028,680) (8,515,680) (9,544,360)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of calculation of basic and diluted net income (loss) per ordinary share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the Period from March 31, 2020 (inception) Through December 31, 2020 Redeemable Class A Ordinary Shares Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income $ 91,362 Net Earnings $ 91,362 Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted (1) 23,000,000 Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ 0.00 Non-Redeemable Class B Ordinary Shares Numerator: Net Loss minus Redeemable Net Earnings Net Loss $ (9,188,357) Redeemable Net Earnings $ (91,362) Non-Redeemable Net Loss $ (9,279,719) Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares Non-Redeemable Class B Ordinary Shares, Basic and Diluted (1) 5,529,817 Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares $ (1.68) As of December 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s shareholders.

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Summary of gross holding gains and fair value of held-to-maturity securities	Gross Amortized Holding Held-To-Maturity Level Cost Gain Fair Value December 31, 2020 U.S. Treasurey Securities (Mature on 01/28/2021) 1 $ 230,091,280 $ 7,515 $ 230,098,795 Liabilities: Warrant Liability – Public Warrants 1 $ 15,985,000 Warrant Liability – Private Placement Warrants 3 $ 9,504,000
Schedule of initial measurement of key inputs for Private Placement Warrants and Public Warrants	Input July 30, 2020 Risk-free interest rate 0.32 % Expected term (years) 5.92 Expected volatility 21.5 % Exercise price $ 11.50 Fair value of Units $ 10.00 December 31,2020 (Initial Input Measurement) Risk-free interest rate 0.36 % Expected term (years) 5.49 Expected volatility 22.7 % Exercise price $ 11.50 Fair value of Shares $ 10.22
Schedule of changes in fair value of warrant liabilities	Private Warrant Placement Level Public Level Liabilities Fair value as of May 28 2020 $ — $ — $ — Initial measurement on July 30, 2020 6,732,000 3 11,270,000 3 18,002,000 Change in fair value 2,772,000 4,715,000 7,487,000 Fair value as of December 31, 2020 $ 9,504,000 3 $ 15,985,000 1 $ 25,489,000

ORGANIZATION AND PLAN OF BUSI_2

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details) - USD ($)	Jul. 30, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Private placement warrants issued		6,600,000
Price of warrant		$ 1
Proceeds from sale of Private Placement Warrants		$ 6,600,000
Transaction Costs		13,273,096
Underwriting fees		4,600,000
Deferred underwriting fees		8,050,000
Other offering costs		623,096
Offset against the proceeds of IPO in equity		12,605,837
Transaction cost expense		$ 667,259
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account		80.00%
Redemption of shares calculated based on business days prior to consummation of business combination (in days)		2 days
Minimum net tangible assets upon consummation of the business combination		$ 5,000,001
Threshold percentage of public shares subject to redemption without the company's prior written consent		15.00%
Obligation to redeem public shares if entity does not complete a business combination (as a percent)		100.00%
Threshold business days for redemption of public shares		10 days
Maximum net interest to pay dissolution expenses		$ 100,000
Business acquires voting percentage		50.00%
Cash		$ 792,416
Cash and marketable securities held in Trust Account		230,091,362
Working capital deficit		$ 276,444
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	23,000,000	23,000,000
Unit price	$ 10	$ 10
Proceeds from issuance of units	$ 230,000,000
Investment of Cash into Trust Account	$ 230,000,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	3,000,000	3,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Private placement warrants issued		6,600,000
Price of warrant		$ 1
Proceeds from sale of Private Placement Warrants		$ 6,600,000

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2020	Jul. 30, 2020
BALANCE SHEET
Warrant Liability			$ 25,489,000
Total Liabilities			34,398,811
Additional Paid in Capital			14,187,406
Accumulated deficit			(9,188,357)
STATEMENTS OF OPERATIONS
Changes in fair value of warrant liabilities			7,487,000
Offering costs allocated to warrant liability		$ 667,259	667,259
Net loss		1,752,939	(9,188,357)
STATEMENT OF CASH FLOWS
Net loss		(1,752,939)	9,188,357
Change in fair value of warrant liability		(2,500,000)	7,487,000
Offering costs allocated to warrant liability		667,259	667,259
Initial classification of warrant liability		18,002,000	18,002,000
Initial classification of common stock subject to possible redemption		200,344,480	200,344,480
Change in value of common stock subject to possible redemption		2,351,240	(9,544,360)
As Previously Reported
BALANCE SHEET
Total Liabilities	$ 8,095,030	8,095,030	8,909,811	$ 8,627,236
Ordinary Shares Subject to Possible Redemption	218,272,100	218,272,100	217,317,800	218,346,480
Additional Paid in Capital	5,079,112	5,079,112	6,033,402	5,004,732
Accumulated deficit	(79,802)	(79,802)	(1,034,098)	(5,415)
STATEMENTS OF OPERATIONS
Net loss	$ 75,068	$ (79,802)	$ (1,034,098)
Earnings Per Share, Basic and Diluted	$ (0.02)	$ (0.02)	$ (0.19)
STATEMENT OF CASH FLOWS
Net loss	$ (75,068)	$ 79,802	$ 1,034,098
Initial classification of common stock subject to possible redemption		218,346,480	218,346,480
Change in value of common stock subject to possible redemption		(74,380)	(1,028,680)
Adjustments
BALANCE SHEET
Warrant Liability	15,502,000	15,502,000	25,489,000	18,002,000
Total Liabilities	15,502,000	15,502,000	25,489,000	18,002,000
Ordinary Shares Subject to Possible Redemption	(15,502,000)	(15,502,000)	(25,489,000)	(18,002,000)
Additional Paid in Capital	(1,832,896)	(1,832,896)	8,154,004	667,079
Accumulated deficit	1,832,741	1,832,741	(8,154,259)	(667,259)
STATEMENTS OF OPERATIONS
Changes in fair value of warrant liabilities	2,500,000	2,500,000	7,487,000
Offering costs allocated to warrant liability	667,259	667,259	667,259
Net loss	$ (1,832,741)	$ 1,832,741	$ (8,154,259)
Earnings Per Share, Basic and Diluted	$ 0.32	$ 0.32	$ (1.49)
STATEMENT OF CASH FLOWS
Net loss	$ 1,832,741	$ (1,832,741)	$ 8,154,259
Change in fair value of warrant liability		(2,500,000)	7,487,000
Offering costs allocated to warrant liability	667,259	667,259	667,259
Initial classification of warrant liability		18,002,000	18,002,000
Initial classification of common stock subject to possible redemption		(18,002,000)	(18,002,000)
Change in value of common stock subject to possible redemption		2,425,620	(8,515,680)
Restatement of warrants as derivative liabilities
BALANCE SHEET
Warrant Liability	15,502,000	15,502,000	25,489,000	18,002,000
Total Liabilities	23,597,030	23,597,030	34,398,811	26,629,236
Ordinary Shares Subject to Possible Redemption	202,770,110	202,770,110	191,828,800	200,344,480
Additional Paid in Capital	3,246,216	3,246,216	14,187,406	5,671,811
Accumulated deficit	1,752,939	1,752,939	(9,188,357)	(672,674)
STATEMENTS OF OPERATIONS
Changes in fair value of warrant liabilities	2,500,000	2,500,000	7,487,000
Offering costs allocated to warrant liability	667,259	667,259	667,259
Net loss	$ (1,757,673)	$ 1,752,939	$ (9,188,357)
Earnings Per Share, Basic and Diluted	$ 0.30	$ 0.30	$ (1.68)
STATEMENT OF CASH FLOWS
Net loss	$ 1,757,673	$ (1,752,939)	$ 9,188,357
Offering costs allocated to warrant liability	667,259	667,259	667,259
Class A ordinary shares
BALANCE SHEET
Ordinary Shares Subject to Possible Redemption			$ 382
STATEMENTS OF OPERATIONS
Earnings Per Share, Basic and Diluted			$ 0
Class A ordinary shares \| As Previously Reported
BALANCE SHEET
Ordinary Shares Subject to Possible Redemption	117	117	$ 127	117
Class A ordinary shares \| Adjustments
BALANCE SHEET
Ordinary Shares Subject to Possible Redemption	155	155	255	180
Class A ordinary shares \| Restatement of warrants as derivative liabilities
BALANCE SHEET
Ordinary Shares Subject to Possible Redemption	$ 272	$ 272	382	$ 297
Class B ordinary shares
BALANCE SHEET
Ordinary Shares Subject to Possible Redemption			$ 575
STATEMENTS OF OPERATIONS
Earnings Per Share, Basic and Diluted			$ (1.68)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted net income (loss) per ordinary share (Details)	9 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Numerator: Earnings allocable to Ordinary Shares
Interest Income	$ 91,362
Net Earnings	(9,188,357)
Redeemable Class A Common Stock
Numerator: Earnings allocable to Ordinary Shares
Interest Income	91,362
Net Earnings	$ 91,362
Denominator: Weighted Average Ordinary Shares
Weighted average ordinary shares Basic and Diluted \| shares	23,000,000
Earnings/Basic and Diluted Ordinary Shares \| $ / shares	$ 0
Non Redeemable Class B Common Stock
Numerator: Earnings allocable to Ordinary Shares
Net Earnings	$ (9,188,357)
Redeemable Net Earnings	(91,362)
Non-Redeemable Net Loss	$ (9,279,719)
Denominator: Weighted Average Ordinary Shares
Weighted average ordinary shares Basic and Diluted \| shares	5,529,817
Earnings/Basic and Diluted Ordinary Shares \| $ / shares	$ (1.68)

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional information (Details) - USD ($)	6 Months Ended	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2020	Mar. 31, 2020
Offering costs including underwriting, legal, accounting and other expenses incurred through the Initial Public Offering		$ 13,273,096
Unrecognized tax benefits		0
Amount accrued for interest and penalties		0
Cash, FDIC insured amount		$ 250,000
Dilutive securities		0
Offering costs allocated to warrant liability	$ 667,259	$ 667,259
Class A ordinary shares
Ordinary shares, shares subject to possible redemption		21,731,790
Class A ordinary shares \| Warrant Liabilities
Exclusion of shares in the calculation of diluted income (loss) per share		18,100,000
Class A ordinary shares
Ordinary shares, shares subject to possible redemption		19,182,880	19,182,880

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - $ / shares	Jul. 30, 2020	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit		1
Number of shares issuable per warrant		1
Exercise price of warrants		$ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability (in shares)	23,000,000	23,000,000
Unit price	$ 10	$ 10
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of 23,000,000 Units, net of underwriting discounts, offering costs and warrant liability (in shares)	3,000,000	3,000,000
Number of warrants in a unit		0.5

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details)	9 Months Ended
PRIVATE PLACEMENT (Details)	Dec. 31, 2020USD ($)$ / sharesshares
PRIVATE PLACEMENT
Number of warrants to purchase shares issued \| shares	6,600,000
Price of warrants \| $ / shares	$ 1
Aggregate purchase price \| $	$ 6,600,000
Number of shares per warrant \| shares	1
Exercise price of warrant \| $ / shares	$ 11.50

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details)	Jul. 30, 2020shares	May 29, 2020shares	May 31, 2020USD ($)D$ / sharesshares	Dec. 31, 2020USD ($)D
Related Party Transaction [Line Items]
Aggregate purchase price \| $				$ 25,000
Over-allotment option
Related Party Transaction [Line Items]
Shares subject to forfeiture	0
Founder Shares \| Sponsor \| Class B ordinary shares
Related Party Transaction [Line Items]
Number of shares issued			5,750,000
Aggregate purchase price \| $			$ 25,000
Number of shares transferred (in shares)		155,000
Shares subject to forfeiture		750,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares			$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D			20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D			30	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional information (Details) - USD ($)	Nov. 27, 2020	Aug. 12, 2020	Jul. 28, 2020	Nov. 30, 2020	Dec. 31, 2020	May 28, 2020
Related Party Transaction [Line Items]
Repayment of promissory note - related party					$ 186,760
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note						$ 300,000
Working Capital Facility
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 1,500,000
Outstanding balance of related party note					0
Amount deposited		900,000
Maximum fund withdrawals		$ 1,500,000
Reduction in deposits				$ 849,960
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month			$ 10,000
Fees waived as part of amended administrative service agreement	$ 30,000
Expense incurred					20,000
Working Capital Loans
Related Party Transaction [Line Items]
Outstanding balance of related party note					0
Maximum Loans Convertible Into Warrants					$ 1,500,000
Price of warrants (in dollars per share)					$ 1

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2020USD ($)$ / shares	Jul. 27, 2020item
COMMITMENTS AND CONTINGENCIES
Maximum number of demands for registration of securities \| item		3
Cash underwriting discount per unit \| $ / shares	$ 0.20
Cash underwriting discount paid \| $	$ 4,600,000
Deferred fee per unit \| $ / shares	$ 0.35
Deferred underwriting fee payable \| $	$ 8,050,000

SHAREHOLDERS' EQUITY - Preferen

SHAREHOLDERS' EQUITY - Preference Shares (Details)	Dec. 31, 2020$ / sharesshares
SHAREHOLDERS' EQUITY
Preference shares, par value \| $ / shares	$ 0.0001
Preference shares, shares authorized	5,000,000
Preference shares, shares issued	0
Preference shares, shares outstanding	0

SHAREHOLDERS' EQUITY - Ordinary

SHAREHOLDERS' EQUITY - Ordinary shares (Details)	Dec. 31, 2020Vote$ / sharesshares	Mar. 31, 2020shares
Class of Stock [Line Items]
Threshold conversion ratio of stock	20.00%
Class A ordinary shares
Class of Stock [Line Items]
Ordinary shares, shares authorized	500,000,000
Ordinary shares, par value \| $ / shares	$ 0.0001
Common shares, votes per share \| Vote	1
Ordinary shares, shares issued	3,817,120
Ordinary shares, shares outstanding	1,268,220
Ordinary shares, shares subject to possible redemption	19,182,880	19,182,880
Class B ordinary shares
Class of Stock [Line Items]
Ordinary shares, shares authorized	50,000,000
Ordinary shares, par value \| $ / shares	$ 0.0001
Common shares, votes per share \| Vote	1
Ordinary shares, shares issued	5,750,000
Ordinary shares, shares outstanding	5,750,000

WARRANT LIABILITY (Details)

WARRANT LIABILITY (Details) - Warrant Liabilities	9 Months Ended
WARRANT LIABILITY (Details) - Warrant Liabilities	Dec. 31, 2020D$ / shares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Public Warrants expiration term	5 years
Threshold period for filling registration statement after business combination	15 days
Threshold period for registration statement to be effective after which warrants can be exercised on a cashless basis	60 days
Redemption price per public warrant (in dollars per share) \| $ / shares	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants \| D	20
Threshold consecutive trading days for redemption of public warrants \| D	30
Stock price trigger for redemption of public warrants (in dollars per share) \| $ / shares	$ 18
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination \| $ / shares	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days for calculating Market Value \| D	20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	180.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details)	Dec. 31, 2020USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Cash and marketable securities held in Trust Account	$ 230,091,362
U.S. Treasury Securities
Schedule of Held-to-maturity Securities [Line Items]
Cash and marketable securities held in Trust Account	230,091,280
Cash
Schedule of Held-to-maturity Securities [Line Items]
Cash and marketable securities held in Trust Account	$ 82

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair value on recurring basis (Details)	Dec. 31, 2020USD ($)
U.S. Treasury Securities \| Level 1
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Amortized Cost	$ 230,091,280
Gross Holding Gains	7,515
Fair Value	230,098,795
Public Warrant \| Level 1
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Fair Value	15,985,000
Private Placement Warrants \| Level 3
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]
Fair Value	$ 9,504,000

FAIR VALUE MEASUREMENTS - Initi

FAIR VALUE MEASUREMENTS - Initial measurement of key inputs for Private Placement Warrants and Public Warrants (Details)	Dec. 31, 2020$ / shares	Jul. 30, 2020$ / shares
Level 3 \| Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement		0.32
Level 3 \| Expected term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement		5.92
Level 3 \| Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement		21.50
Level 3 \| Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement		11.50
Level 3 \| Fair value of Units
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement		10
Level 1 \| Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement	0.36
Level 1 \| Expected term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement	5.49
Level 1 \| Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement	22.7
Level 1 \| Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement	11.50
Level 1 \| Fair value of Units
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants initial measurement	10.22

FAIR VALUE MEASUREMENTS - Subse

FAIR VALUE MEASUREMENTS - Subsequent measurement on changes in fair value of warrant liabilities (Details) - USD ($)	5 Months Ended	7 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Jul. 30, 2020
Warrant Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on July 30, 2020			$ 18,002,000
Change in fair value		$ 7,487,000
Fair value, ending	$ 25,489,000	25,489,000
Public Warrant \| Fair Value, Recurring
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on July 30, 2020				$ 11,300,000
Change in fair value	11,270,000
Fair value, ending	16,000,000	16,000,000
Public Warrant \| Level 1
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, ending	15,985,000	15,985,000
Public Warrant \| Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on July 30, 2020			11,270,000
Change in fair value		4,715,000
Private Placement Warrants \| Fair Value, Recurring
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on July 30, 2020				$ 6,700,000
Fair value, ending	9,100,000	9,100,000
Private Placement Warrants \| Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement on July 30, 2020			$ 6,732,000
Change in fair value		2,772,000
Fair value, ending	$ 9,504,000	$ 9,504,000

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional information (Details)	Jul. 30, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares	Dec. 31, 2020USD ($)$ / sharesshares	Sep. 30, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of shares in a unit \| shares				1
Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Number of shares in a unit \| shares	1
Warrant Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of initial measurement on fair value of warrant					$ 18,002,000
Aggregate value of subsequent measurement on fair value of warrant		$ 25,489,000	$ 25,489,000	$ 25,489,000
Fair values of warrants transfers out of Level 3			$ 7,487,000
Public Warrant \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of initial measurement on fair value of warrant	$ 11,300,000
Fair value of initial measurement per warrant \| $ / shares	0.98	1.39	1.39	1.39
Aggregate value of subsequent measurement on fair value of warrant		$ 16,000,000	$ 16,000,000	$ 16,000,000
Fair values of warrants transfers out of Level 3		$ 11,270,000
Number of warrants in a unit \| shares	1
Private Placement Warrants \| Fair Value, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of initial measurement on fair value of warrant	$ 6,700,000
Fair value of initial measurement per warrant \| $ / shares	1.02	1.44	1.44	1.44
Aggregate value of subsequent measurement on fair value of warrant		$ 9,100,000	$ 9,100,000	$ 9,100,000
Level 1 \| Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of subsequent measurement on fair value of warrant		15,985,000	15,985,000	15,985,000
Level 3 \| Public Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of initial measurement on fair value of warrant					11,270,000
Fair values of warrants transfers out of Level 3			4,715,000
Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate value of initial measurement on fair value of warrant					$ 6,732,000
Aggregate value of subsequent measurement on fair value of warrant		$ 9,504,000	9,504,000	$ 9,504,000
Fair values of warrants transfers out of Level 3			$ 2,772,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent event - Merger Agreement	Jan. 07, 2021USD ($)$ / sharesshares
Subsequent Event [Line Items]
Ordinary shares, par value \| $ / shares	$ 0.001
Cash consideration in merger \| $	$ 50,000,000
purchase price per share \| $ / shares	$ 10
PIPE Investment Under Subscription Agreement
Subsequent Event [Line Items]
Number of shares subscribed by PIPE investors as a part of merger agreement \| shares	15,000,000
Aggregate purchase price/PIPE Investment \| $	$ 150,000,000